EU Official Journal L-series Daily Listing - 18 Legislative Acts

The EU Official Journal L-series daily listing for 7 April 2026 publishes 18 legislative acts, including two Commission Delegated Regulations amending Union Registry functions under land use and greenhouse gas reduction regulations (LULUCF), two Commission Implementing Regulations on pesticide sampling/analysis methods and third-country poultry import authorisations, and Council Decisions on export credits for civil aircraft and Committee of the Regions appointments.

Consumer Alert: Investment Scams Proliferate on Meta Platforms

Washington Attorney General Nick Brown issued a consumer alert warning Washingtonians about fraudulent investment schemes on Meta platforms (Facebook, Instagram, WhatsApp). The alert describes pump-and-dump scams, confidence scams, and cryptocurrency fraud using deepfake technology and unauthorized celebrity endorsements. AG Brown was one of 42 state AGs who previously urged Meta to address scam advertisements.

BOI Reporting Exemptions Under Corporate Transparency Act

FinCEN issued an FAQ clarifying that domestic U.S. companies are exempt from Beneficial Ownership Information (BOI) reporting under the Corporate Transparency Act following an interim final rule published March 26, 2025. The rule revised the definition of 'reporting company' to include only foreign entities registered to do business in U.S. states. Foreign entities still subject to reporting must file by April 25, 2025 (if registered before March 26, 2025) or within 30 days of registration (if registered on or after March 26, 2025).

U.S. Companies Exempt from BOI Reporting Under CTA Revision

FinCEN published an interim final rule on March 26, 2025, exempting all U.S. domestic entities and their beneficial owners from beneficial ownership information reporting under the Corporate Transparency Act. The revised rule narrows reporting obligations to foreign entities registered to do business in the U.S. Foreign entities registered before March 26, 2025 must file by April 25, 2025, while those registered on or after that date have 30 calendar days from registration notice to file.

FinCEN Exempts US Companies from BOI Reporting

FinCEN published an interim final rule on March 26, 2025, exempting all US companies and their beneficial owners from Beneficial Ownership Information reporting requirements under the Corporate Transparency Act. The rule revised the definition of "reporting company" to include only foreign entities registered to do business in the US, eliminating obligations for domestic companies. Foreign reporting companies face new compliance deadlines.

Beneficial Ownership Reporting - Interim Final Rule Exempts US Entities

FinCEN issued an interim final rule removing beneficial ownership information (BOI) reporting requirements for U.S. companies and U.S. persons under the Corporate Transparency Act. The rule narrows the definition of "reporting company" to only foreign entities registered to do business in the U.S. Foreign reporting companies must file BOI reports within 30 days of publication or registration notice. U.S. entities and beneficial owners are fully exempt from CTA reporting obligations.

Whistleblower Incentives and Protections NPRM

FinCEN published a Notice of Proposed Rulemaking (NPRM) on whistleblower incentives and protections, seeking public comment on a proposed program to incentivize reporting of Bank Secrecy Act violations. The NPRM outlines potential financial rewards for whistleblowers whose tips lead to successful enforcement actions exceeding $1 million in sanctions. Comments are being accepted through the Federal Register docket.

Anti-Money Laundering and Countering the Financing of Terrorism Programs NPRM

FinCEN has released a Notice of Proposed Rulemaking (NPRM) regarding Anti-Money Laundering and Countering the Financing of Terrorism (AML/CFT) Programs. The proposed rulemaking seeks public comment on potential new or revised requirements for financial institutions' AML/CFT programs. This represents a significant regulatory initiative that may affect compliance obligations across the financial services sector.

FinCEN Proposes Rule to Reform AML/CFT Programs Under Bank Secrecy Act

FinCEN issued a proposed rule on April 7, 2026, to fundamentally reform anti-money laundering and countering the financing of terrorism (AML/CFT) programs for financial institutions under the Bank Secrecy Act. The proposal would shift compliance obligations from volume-based metrics to effectiveness-based evaluation, empower institutions to allocate resources based on their risk assessments, and clarify examiner expectations for program requirements. The rule withdraws a prior proposed rule from July 3, 2024, and introduces a notice and consultation framework between federal banking supervisors and FinCEN.

ALT001 drug trial for MSA-C cerebellar subtype

The National Library of Medicine registered a new clinical trial on ClinicalTrials.gov for ALT001, an investigational drug for the cerebellar subtype of Multiple System Atrophy (MSA-C). The trial is categorized as an interventional study. ClinicalTrials.gov is a publicly accessible database operated by the NIH as required under FDA regulations for clinical trial registration and results reporting.